10x Genomics Days Sales in Receivables 2018-2025 | TXG
10x Genomics days sales in receivables from 2018 to 2025. Days sales in receivables can be defined as the average number of days it takes to collect outstanding receiveable amounts from customers.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.691B | $0.611B |
| 10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $47.594B | 60.55 |
| Hims & Hers Health (HIMS) | United States | $12.830B | 133.30 |
| Doximity (DOCS) | United States | $11.392B | 52.74 |
| Tempus AI (TEM) | United States | $10.965B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.223B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.794B | 59.28 |
| Hinge Health (HNGE) | United States | $3.587B | 0.00 |
| Privia Health (PRVA) | United States | $2.402B | 164.17 |
| Schrodinger (SDGR) | United States | $1.650B | 0.00 |
| Phreesia (PHR) | United States | $1.610B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.565B | 0.00 |
| Azenta (AZTA) | United States | $1.555B | 72.25 |
| Enovis (ENOV) | United States | $1.551B | 8.65 |
| Omnicell (OMCL) | United States | $1.318B | 23.25 |
| Evolent Health (EVH) | United States | $1.098B | 93.50 |
| Claritev (CTEV) | United States | $0.686B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.560B | 0.00 |
| Standard BioTools (LAB) | United States | $0.558B | 0.00 |
| Veradigm (MDRX) | United States | $0.523B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.514B | 0.00 |
| Talkspace (TALK) | United States | $0.422B | 126.00 |
| TruBridge (TBRG) | United States | $0.349B | 775.00 |
| Outset Medical (OM) | United States | $0.312B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.268B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.265B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.241B | 0.00 |
| CapsoVision (CV) | United States | $0.198B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.165B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.162B | 0.00 |
| American Well (AMWL) | United States | $0.136B | 0.00 |
| Pulmonx (LUNG) | United States | $0.133B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.116B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.115B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.106B | 0.00 |
| CareCloud (CCLD) | United States | $0.100B | 3.82 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.085B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.053B | 0.00 |
| HeartBeam (BEAT) | United States | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.027B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.022B | 0.00 |
| Precipio (PRPO) | United States | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.015B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |